Endoscopic plication compared to laparoscopic fundoplication in the treatment of gastroesophageal reflux disease: a systematic review and meta-analysis
- PMID: 37407715
- DOI: 10.1007/s00464-023-10202-x
Endoscopic plication compared to laparoscopic fundoplication in the treatment of gastroesophageal reflux disease: a systematic review and meta-analysis
Abstract
Introduction: Endoscopic plication offers an alternative to surgical fundoplication for treatment of gastroesophageal reflux disease (GERD). This systematic review and meta-analysis evaluate outcomes following endoscopic plication compared to laparoscopic fundoplication.
Methods and procedures: Systematic search of MEDLINE, Embase, Scopus, and Web of Science was conducted in September 2022. Study followed PRISMA guidelines. Studies comparing endoscopic plication to laparoscopic fundoplication with n > 5 were included. Primary outcome was PPI cessation, with secondary outcomes including complications, procedure duration, length of stay, change in lower esophageal sphincter (LES) tone, and DeMeester score.
Results: We reviewed 1544 studies, with five included comparing 105 (46.1%) patients receiving endoscopic plication (ENDO) to 123 (53.9%) undergoing laparoscopic fundoplication (LAP). Average patient age was 47.6 years, with those undergoing plication being younger (46.4 ENDO vs 48.5 LAP). BMI (26.6 kg/m2 ENDO vs 26.2 kg/m2 LAP), and proportion of females (42.9% ENDO vs 37.4% LAP) were similar. Patients undergoing laparoscopic procedures had worse baseline LES pressure (12.8 mmHg ENDO vs 9.0 mmHg LAP) and lower preoperative DeMeester scores (34.6 ENDO vs. 34.1 LAP). The primary outcome demonstrated that 89.2% of patients undergoing laparoscopic fundoplication discontinued PPI compared to 69.4% for those receiving plication. Meta-analysis revealed that plication had significantly reduced odds of PPI discontinuation (OR 0.27, studies = 3, 95% CI 0.12 to 0.64, P = 0.003, I2 = 0%). Secondary outcomes demonstrated that odds of complications (OR 1.46, studies = 4, 95% CI 0.34 to 6.32, P = 0.62, I2 = 0%), length of stay (MD - 1.37, studies = 3, 95% CI - 3.48 to 0.73, P = 0.20, I2 = 94%), and procedure durations were similar (MD 0.78, studies = 3, 95% CI - 39.70 to 41.26, P = 0.97, I2 = 98%).
Conclusions: This is the first meta-analysis comparing endoscopic plication to laparoscopic fundoplication. Results demonstrate greater likelihood of PPI discontinuation with laparoscopic fundoplication with similar post-procedural risk.
Keywords: Endoscopic plication; Fundoplication; GERD; Gastroesophageal reflux disease; Gastroplication; Nissen; Toupet.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Fundoplication significantly improves objective and subjective reflux outcomes-a meta-analysis.Surg Endosc. 2025 Jul;39(7):4496-4504. doi: 10.1007/s00464-025-11856-5. Epub 2025 May 29. Surg Endosc. 2025. PMID: 40442360 Free PMC article.
-
Early results of magnetic sphincter augmentation versus fundoplication for gastroesophageal reflux disease: Systematic review and meta-analysis.Int J Surg. 2018 Apr;52:82-88. doi: 10.1016/j.ijsu.2018.02.041. Epub 2018 Feb 20. Int J Surg. 2018. PMID: 29471155
-
LINX® magnetic esophageal sphincter augmentation versus Nissen fundoplication for gastroesophageal reflux disease: a systematic review and meta-analysis.Surg Endosc. 2017 Aug;31(8):3078-3084. doi: 10.1007/s00464-016-5370-3. Epub 2016 Dec 15. Surg Endosc. 2017. PMID: 27981382
-
Fundoplication in laparoscopic Heller's cardiomyotomy for achalasia.Cochrane Database Syst Rev. 2022 Dec 8;12(12):CD013386. doi: 10.1002/14651858.CD013386.pub2. Cochrane Database Syst Rev. 2022. PMID: 36478353 Free PMC article.
-
Efficacy of Laparoscopic Nissen Fundoplication vs Transoral Incisionless Fundoplication or Proton Pump Inhibitors in Patients With Gastroesophageal Reflux Disease: A Systematic Review and Network Meta-analysis.Gastroenterology. 2018 Apr;154(5):1298-1308.e7. doi: 10.1053/j.gastro.2017.12.021. Epub 2018 Jan 3. Gastroenterology. 2018. PMID: 29305934
References
-
- Richter JE, Rubenstein JH (2018) Presentation and epidemiology of gastroesophageal reflux disease. Gastroenterology 154(2):267–276. https://doi.org/10.1053/j.gastro.2017.07.045 - DOI - PubMed
-
- Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ (2022) ACG clinical guideline for the diagnosis and management of gastroesophageal reflux disease. Off J Am Coll Gastroenterol ACG 117(1):27. https://doi.org/10.14309/ajg.0000000000001538 - DOI
-
- Marchese M, Spada C, Costamagna G (2006) Endoluminal fundoplication. Minim Invasive Ther Allied Technol 15(6):356–365. https://doi.org/10.1080/13645700601040594 - DOI - PubMed
-
- Bell RCW (2015) Randomized controlled trial of transoral incisionless fundoplication vs. proton pump inhibitors for treatment of gastroesophageal reflux disease. Am J Gastroenterol 110(11):1621–1623. https://doi.org/10.1038/ajg.2015.324 - DOI - PubMed
-
- Kahrilas P, Hunter J, Bell R et al (2014) Transoral fundoplication provides better GERD symptom control than PPIs in patients with troublesome regurgitation: a multicenter sham-controlled randomized clinical trial. Am J Gastroenterol 109:S13–S13 - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials